1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
evoke and evoke+ : design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Glucose-dependent insulinotropic polypeptide (GIP)
(
- Contribution to journal › Scientific review
- 2024
-
Mark
Baseline Characteristics from Evoke and Evoke+ : Two Phase 3 Randomized Placebo-controlled Trials of Oral Semaglutide in Patients with Early Alzheimer's Disease (P11-9.013)
(
- Contribution to journal › Published meeting abstract
- 2023
-
Mark
Identification of bile acid-CoA:amino acid N-acyltransferase as the hepatic N-acyl taurine synthase for polyunsaturated fatty acids
(
- Contribution to journal › Article
- 2021
-
Mark
Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy – Pump vs multiple daily injections, a secondary analysis of an observational cohort study
(
- Contribution to journal › Article
- 2019
-
Mark
Continuous glucose monitoring in pregnant women with type 1 diabetes : an observational cohort study of 186 pregnancies
(
- Contribution to journal › Article
- 2016
-
Mark
Palaeolithic diet decreases fasting plasma leptin concentrations more than a diabetes diet in patients with type 2 diabetes : A randomised cross-over trial
(
- Contribution to journal › Article